Bacterial responses to plasma may forecast mild vs severe COVID-19
Researchers have discovered that E. coli bacteria can be used to analyze human plasma samples to predict the severity of COVID-19 cases. By measuring the growth patterns of the bacteria in response to plasma, scientists can distinguish between mild and severe disease trajectories.
Why it matters
This innovative use of biological information processing offers a potential new diagnostic tool that could improve patient triage and treatment outcomes.
edited by Gaby Clark , reviewed by Andrew Zinin
The article is a straightforward report on scientific research published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in